Hepatitis B Vaccine Delivered Trans-dermally by MAP

Clinical trial NCT06800131 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06800131
Sponsor: International Vaccine Institute
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatitis B Vaccine

Start date: 2025-02-05
Primary completion: 2026-08-05
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.